Development of Insulin-like peptide 5 (INSL5) peptide analogues as novel therapeutics. Insulin-like peptide 5 (INSL5) is a naturally-occurring hormone in the body that likely plays a role in the control of appetite. This project aims to develop new molecules based on INSL5 that could be suitable for use as drugs to treat various appetite-related disorders, such as obesity (where patients eat too much) or anorexia (where patients eat too little).
The development and evaluation of a new therapy for the prevention and treatment of bacterial infections in hospitals. The technology used in this project will enable products to be developed from the Australian dairy industry which may safely provide protection and treatment for diarrhoea acquired in hospitals for which there are few effective options. The product will be cost effective and can be used as a public health tool to control outbreaks in those most susceptible to severe disease.
Development of novel cereal grain products for wheat and gluten intolerant Australians. Many Australians claim to have wheat or gluten intolerances and this has led to the growing demand for wheat and gluten free grain products. The most common problems reported by individuals relate to gut symptoms and chronic fatigue. There are a number of dietary factors in cereal products that may be responsible for triggering these symptoms including the presence of poorly absorbed carbohydrates and wheat g ....Development of novel cereal grain products for wheat and gluten intolerant Australians. Many Australians claim to have wheat or gluten intolerances and this has led to the growing demand for wheat and gluten free grain products. The most common problems reported by individuals relate to gut symptoms and chronic fatigue. There are a number of dietary factors in cereal products that may be responsible for triggering these symptoms including the presence of poorly absorbed carbohydrates and wheat gluten itself. This partnership between Monash University and George Weston Foods will develop novel food products that will be better tolerated by Australians reporting wheat and gluten intolerances. This will help provide the cereal industry with a competitive edge and improve the sustainability of the Australian agriculture sector.Read moreRead less
Central pathways regulating visceral pain. This project aims to investigate the neural pathways within the spinal cord and brain processing colorectal pain perception. The project aims to identify the spinal cord neurons relaying colorectal signalling into the brain and the influence of descending modulation from the brainstem upon these pathways. The outcomes will greatly benefit fundamental understanding of the central pathways processing visceral pain.
Wiring the gut's nervous system: formation and maturation of synapses. This project aims to determine how nerve circuits controlling intestinal functions develop; specifically how communication between specific nerve cells is established once they appear in the embryonic gut. It will fill a major hole in existing knowledge of mechanisms regulating the development of normal digestive behaviours.
Tissue-like, nonlinearly elastic nanobiomaterials for soft tissue regeneration. The purpose of this project is to advance the discipline of soft tissue engineering and regeneration with novel biomaterials, nanotechnology and novel clinical treatment concepts. The key outcomes include new elastic tissue-like nanobiomaterials, new varieties of medical implants and innovative treatment methodology.
Harnessing lipid nano-assembly for next generation functional foods and pharmaceutical products. Nature assembles lipid molecules from our diet into useful structures in our gastrointestinal tract with remarkable precision and versatility. By understanding and harnessing these processes we can design new lipid-based nanomaterials leading to more effective functional foods and pharmaceutical products with reduced side effects.